A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer (The “METRIC” Study)

Type of Cancer
Breast Oncology

Site
Hackensack

Sponsor
Celldex

Protocol Number
CDX011-04

Cancer Diagnosis
Breast

Phase of Trial
Phase III

To Learn More Call
201-510-0910